Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

December 2017 Issue of The Translational Scientist

Welcome to the December issue of The Translational Scientist! This month, we look at a multiple sclerosis drug being repurposed in the fight against microbial resistance, and cover the opposite of innovation: exnovation. We also sit down with Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute (M4I), Distinguished Professor and Limburg Chair at Maastricht University, The Netherlands. Stay tuned for more of the latest news and views in translational science throughout the month…

Register to download

Register here to download any issue of The Translational Scientist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Disease Area Drug discovery

Pain and Vision Gain

| Roisin McGuigan

An analgesic is helping researchers explore new drug targets for sight-threatening diseases

Outside the Lab Cancer

A Deadly Combination

| Roisin McGuigan

Diabetes and obesity often go hand-in-hand, with devastating effects on public health

Disease Area Diagnostics & prognostics

Dark Fields and Diagnostic Disks

| Michael Schubert

New devices for detecting tuberculosis may speed up diagnosis and improve treatment

Outside the Lab Metabolism & Diabetes

Trimming the Fat

| Roisin McGuigan

Could weight management replace medication as the first line treatment for type II diabetes?

Research Field Drug discovery

Believe in RNAi

| Geert Cauwenbergh

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender

Tools & Techniques Cancer

Think Small

| Roisin McGuigan

Nanotechnology helps track down micrometastases missed by MRI

Disease Area Microbiology

From MS to AMR

| Roisin McGuigan

A drug used to treat MS could be repurposed to treat infections in cystic fibrosis patients

Outside the Lab Cardiovascular

Innovation Versus Exnovation

| Roisin McGuigan

Sometimes, medical innovation may need to go backwards to go forwards

Tools & Techniques Analytical science

Collaborating for the Clinical Win

| Joanna Cummings

Sitting Down With... Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute

Other issues of 2017